Last ¥682.00 JPY
Change Today +1.00 / 0.15%
Volume 760.0K
4912 On Other Exchanges
As of 1:00 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

lion corp (4912) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/27/15 - ¥688.00
52 Week Low
03/17/14 - ¥542.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LION CORP (4912)

Related News

No related news articles were found.

lion corp (4912) Related Businessweek News

No Related Businessweek News Found

lion corp (4912) Details

Lion Corporation, together with its subsidiaries, manufactures and sells consumer and industrial products in Japan and internationally. It operates in four segments: Consumer Products, Industrial Products, Overseas, and Other. The company offers oral care products, such as toothpastes, toothbrushes, mouthwashes, interdental products, etc.; beauty care products comprising shampoos, conditioners and treatments, body washes, antiperspirants and deodorants, hair-nourishment treatments, etc.; fabric care products consisting of laundry detergents, fabric softeners, bleaches, anti-static agents, etc.; and living care products, including dishwashing detergents, household cleaners, cooking-aid products, etc. It also provides pharmaceutical products, such as analgesics, cold medicine, antidiarrheal drugs, digestive medicines, eyedrops, tonics and nutrients, insecticides, etc.; gift and channel-specific products, including novelties, gifts, functional food products (mail-order only), etc.; pet supplies consisting of sanitary products, functional pet food, body care and living care products, etc.; and dental products comprising toothpaste, toothbrushes, interdental products, dental chewing gum, supplements, pharmaceuticals, etc. In addition, the company manufactures and sells chemical products, such as chemical intermediate materials, including activators derived from oil and fats, electro-conductive carbon, detergents, and other items for institutional and other industrial uses, as well as provides surfactants and fatty acid nitrogen derivatives. Further, it is involved in the construction; management of real estate, including rental, dealing, and brokerage; transportation and storage; and other activities, as well as in the provision of human resources services. Lion Corporation was founded in 1891 and is headquartered in Tokyo, Japan.

Founded in 1891

lion corp (4912) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lion corp (4912) Key Developments

Lion Corporation Reports Unaudited Consolidated Earnings Results for the Year Ended December 31, 2014; Provides Earnings Guidance for the First Half Ending June 30, 2015 and for the Year Ending December 31, 2015

Lion Corporation reported unaudited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported operating income of ¥12,406 million, ordinary income of ¥14,059 million and net income of ¥7,368 million or ¥26.16 per diluted share on net sales of ¥367,396 million compared to operating income of ¥10,819 million, ordinary income of ¥12,300 million and net income of ¥6,097 million or ¥22.68 per diluted share on net sales of ¥352,005 million reported a year ago. Income before income taxes was ¥13,085 million compared to ¥10,925 million reported a year ago. Purchases of property, plant and equipment was ¥13,124 million compared to ¥14,649 million reported a year ago. Purchase of intangible assets was ¥118 million compared to ¥112 million reported a year ago. Return on equity was 6.2% compared to 5.4% reported a year ago. Cash flows from operating activities were ¥11,738 million compared to ¥22,910 million reported a year ago. For the first half ending June 30, 2015, the company expects to report operating income of ¥4,200 million, ordinary income of ¥4,800 million and net income of ¥2,500 million or ¥9.32 per share on net sales of ¥178,000 million. For the year ending December 31, 2015, the company expects to report operating income of ¥13,500 million, ordinary income of ¥15,000 million and net income of ¥7,500 million or ¥27.97 per share on net sales of ¥375,000 million.

Lion Corporation to Report Fiscal Year 2014 Results on Feb 10, 2015

Lion Corporation announced that they will report fiscal year 2014 results on Feb 10, 2015

Lion Corporation to Release Excedrin LOX

Lion Corporation announced the release of Excedrin LOX, an orally administered painkiller formulated with the antipyretic analgesic ingredient loxoprofen sodium hydrate for the highly effective relief of back, shoulder and other body pain. Excedrin LOX will be available February 4, 2015 at pharmacies and drug stores nationwide. Product features: Formulated with loxoprofen sodium hydrate, an antipyretic analgesic ingredient that boasts superior effectiveness against body pain: This ingredient acts on the source of pain (peripheral nerves), thereby delivering highly effective pain relief, especially against back pain and pain due to stiff shoulders; Prodrug formula is easy on the stomach: Although some antipyretic analgesic ingredients tend to irritate the gastric mucosa, loxoprofen sodium hydrate is a prodrug, meaning that it retains a form that causes minimal irritation during the course of digestion and absorption. Since it is converted to an active antipyretic analgesic ingredient only after absorption, this ingredient is easy on the stomach; Effective with just one tablet per dosage: Small, easytoswallow 9mm tablets; Free of ingredients that cause drowsiness, such as hypnotic sedatives. Active Ingredients (per one tablet): Loxoprofen sodium hydrate: 68.1mg (60mg as anhydride); Efficacy: Relief from back pain, pain due to stiff shoulders, headache, arthralgia, neuralgia, muscle pain, pain from bone fractures, sprains or bruises, menstrual pain, toothache, pain after tooth extraction, sore throat, earache, pain from trauma; Antipyretic effect for relief from chills or fever. Directions for Use and Dosage: Adults (15 years and older): take one tablet up to twice per day upon the development of symptoms. A third dosage is permissible if symptoms recur. Avoid taking on an empty stomach and wait at least four hours before taking again. Take with cold or warm water. Precautions: Receive instructions from a pharmacist and carefully read the attached warnings before use. Ask a healthcare professional before use if having drug or other allergies.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4912:JP ¥682.00 JPY +1.00

4912 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4912.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4912 Industry Range
Price/Earnings 26.1x
Price/Sales 0.5x
Price/Book 1.5x
Price/Cash Flow 27.8x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LION CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at